Behavioral indications for serotonin receptor hypersensitivity in panic disorder

Psychiatry Research

Volumn 25, Issue 1, 1988, Pages 101-104

  Kahn, RenéS ^a   Wetzler, Scott ^a   van Praag, Herman M ^a   Asnis, Gregory M ^a   Strauman, Tim ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

anxiety; m chlorophenylpiperazine; panic disorder; receptor; Serotonin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE;

ADULT; ANXIETY; BEHAVIOR; CLINICAL ARTICLE; DEPRESSION; DRUG SENSITIVITY; DRUG THERAPY; HOSTILITY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PANIC; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; VOLUNTEER;

ADULT; BRAIN; DEPRESSIVE DISORDER; FEAR; FEMALE; HUMAN; INFUSIONS, INTRAVENOUS; MALE; PANIC; PIPERAZINES; RECEPTORS, SEROTONIN; SEROTONIN; SUPPORT, NON-U.S. GOV'T;

EID: 0023676915     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1781(88)90163-1     Document Type: Article

References (13)

1. Neurobiological mechanisms in human anxiety: Evidence supporting central noradrenergic hyperactivity
2. Serotonin function in anxiety: II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects
3. Effect of serotonin uptake inhibitors in anxiety disorders: A double-blind comparison of clompramine and fluvoxamine
4. A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia (SADS)
5. Serotonin and anxiety revisited
6. 1-5-Hydroxytryptophan in the treatment of anxiety disorders
7. Effect of a serotonin precursor and uptake inhibitor in anxiety disorders: A double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo
8. 2 antagonist
9. Further studies of the putative serotonin agonist m-chlorophenylpiperazine Evidence for a serotonin receptor mediated mechanism of action in hum ans
10. Research Diagnostic Criteria: Rationale and reliability
11. Buspirone decreases the activity of 5-hydroxytryptamine-containing dorsal raphe neurons in vitro